• Subscribe
  • Webinars
  • White Papers
  • Buyer's Guide
  • PhotonicsNXT
  • Get Published!
    • Recent Quotes
    My Watchlist
    Indicators
    BioOptics Stock Watch
    Markets
    Stocks
    ETFs
    Tools
    Markets:
    Overview
    News
    Currencies
    International
    Treasuries

    Moderna, Inc. - Common Stock (NQ:MRNA)

    64.75 +1.43 (+2.25%)
    Streaming Delayed Price Updated: 11:09 AM EDT, Aug 17, 2026 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    Price and Volume

    Detailed Quote
    Volume 1,206,160
    Open 64.78
    Bid (Size) 64.72 (100)
    Ask (Size) 64.77 (100)
    Prev. Close 63.32
    Today's Range 62.91 - 65.53
    52wk Range 22.28 - 85.60
    Shares Outstanding 394,000,000
    Dividend Yield N/A
    Chart for (: )
    Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

    Top News

    More News
    News headline image
    Moderna (MRNA): Buy, Sell, or Hold Post Q2 Earnings?
    What a fantastic six months it’s been for Moderna. Shares of the company have skyrocketed 44.2%, hitting $63.36. This was partly due to its solid quarterly r... 
    Via StockStory
    News headline image
    3 Unprofitable Stocks We Keep Off Our Radar
    Unprofitable companies face headwinds as they struggle to keep operating expenses under control. Some may be investing heavily, but the majority fail to conv... 
    Via StockStory

    Performance

    YTD
    +109.8%
    +109.8%
    1 Month
    +4.7%
    +4.7%
    3 Month
    +34.6%
    +34.6%
    6 Month
    +47.4%
    +47.4%
    1 Year
    +130.5%
    +130.5%

    More News

    Read More
    Get insights into the top movers in the S&P500 index of Monday's pre-market session. ↗
    Via Chartmill
    News headline image
    Moderna (MRNA) Q2 2026 Earnings Call Transcript ↗
    Via The Motley Fool
    Topics Earnings
    Stay informed with the top movers within the S&P500 index on Friday. ↗
    Via Chartmill
    Top S&P500 movers in Friday's session ↗
    Via Chartmill
    What's going on in today's pre-market session: S&P500 movers ↗
    Via Chartmill
    News headline image
    Moderna Receives U.S. FDA Approval for Influenza Vaccine mFLUSIVA
    From Moderna, Inc.
    Via ACCESS Newswire
    News headline image
    Prediction: These 2 Stocks Will Keep Winning No Matter What the Market Does ↗
    Via The Motley Fool
    News headline image
    MRNA Q2 Deep Dive: Pipeline Progress and Seasonal Vaccine Dynamics Shape Outlook
    Via StockStory
    News headline image
    Moderna Announces Initiation of Phase 1 Clinical Trial of mRNA-1469, Moderna's Investigational Vaccine Against Bundibugyo Ebolavirus
    From Moderna, Inc.
    Via ACCESS Newswire
    News headline image
    Moderna Q2 Earnings Call Highlights ↗
    Via MarketBeat
    Topics Earnings
    Get insights into the top movers in the S&P500 index of Friday's pre-market session. ↗
    Via Chartmill
    News headline image
    Moderna (NASDAQ:MRNA) Beats Expectations in Q2 CY2026
    Via StockStory
    News headline image
    Moderna Reports Second Quarter 2026 Financial Results and Provides Business Updates
    From Moderna, Inc.
    Via ACCESS Newswire
    News headline image
    Moderna (MRNA) Q2 Earnings: What To Expect
    Via StockStory
    Topics Artificial Intelligence
    News headline image
    1 Healthcare Stock to Keep an Eye On and 2 We Avoid
    Via StockStory
    News headline image
    After Soaring Nearly 90% Thus Far in 2026, Is Moderna's Stock Still a Buy? ↗
    Via The Motley Fool
    News headline image
    Q1 Earnings Highlights: Moderna (NASDAQ:MRNA) Vs The Rest Of The Therapeutics Stocks
    Via StockStory
    Topics Artificial Intelligence
    News headline image
    Moderna: A Stock to Watch or a Risky Bet? ↗
    Via The Motley Fool
    News headline image
    Therapeutics Stocks Q1 Highlights: Moderna (NASDAQ:MRNA)
    Via StockStory
    Topics Artificial Intelligence
    News headline image
    Therapeutics Stocks Q1 Teardown: Amgen (NASDAQ:AMGN) Vs The Rest
    Via StockStory
    Topics Artificial Intelligence Intellectual Property
    News headline image
    Should You Buy Moderna Stock Hand Over Fist Before Aug. 5? ↗
    Via The Motley Fool
    News headline image
    Moderna Is Up 109% in 2026. Jim Cramer Just Called It 'Finally Investable Again.' Is the Stock a No-Brainer Buy on Its Recent Pullback? ↗
    Via The Motley Fool
    News headline image
    Moderna (MRNA): Buy, Sell, or Hold Post Q1 Earnings?
    Via StockStory

    Frequently Asked Questions

    Is Moderna, Inc. - Common Stock publicly traded?
    Yes, Moderna, Inc. - Common Stock is publicly traded.
    What exchange does Moderna, Inc. - Common Stock trade on?
    Moderna, Inc. - Common Stock trades on the Nasdaq Stock Market
    What is the ticker symbol for Moderna, Inc. - Common Stock?
    The ticker symbol for Moderna, Inc. - Common Stock is MRNA on the Nasdaq Stock Market
    What is the current price of Moderna, Inc. - Common Stock?
    The current price of Moderna, Inc. - Common Stock is 64.75
    When was Moderna, Inc. - Common Stock last traded?
    The last trade of Moderna, Inc. - Common Stock was at 08/17/26 11:09 AM ET
    What is the market capitalization of Moderna, Inc. - Common Stock?
    The market capitalization of Moderna, Inc. - Common Stock is 25.51B
    How many shares of Moderna, Inc. - Common Stock are outstanding?
    Moderna, Inc. - Common Stock has 26B shares outstanding.
    Stock Quote API & Stock News API supplied by www.cloudquote.io
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the Privacy Policy and Terms Of Service.
    © 2025 FinancialContent. All rights reserved.